Dermata Therapeutics- Warrants (13/08/2026) Current Assets

As of the most recent data (March 2026), DRMAW shows a current assets of $7M. That compares with $9.7M in the prior-year period — down 27.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DRMAW's current assets is now $7M (was $9.7M) — a 27.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Dermata Therapeutics- Warrants (13/08/2026) is outperforming or lagging.

Tracking DRMAW's current assets over time shows whether Dermata Therapeutics- Warrants (13/08/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $7M That compares with $9.7M in the prior-year period — down 27.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Dermata Therapeutics- Warrants (13/08/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $7M) with ownership activity and broader fundamentals.

Dermata Therapeutics- Warrants (13/08/2026)'s current assets is $7M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.